SPP1 and myeloid sarcoma: Markers of inflammation such as SAA (P < 0.05, Fig. 1e), CRP (P < 0.001, Fig. 1f) and OPN (P < 0.01, Fig. 1g) were more elevated in subjects with the MS as compared with individuals without the MS.